INTRAVITREAL AFLIBERCEPT FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION UNRESPONSIVE TO RANIBIZUMAB THERAPY-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

INTRAVITREAL AFLIBERCEPT FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION UNRESPONSIVE TO RANIBIZUMAB THERAPY

Published:2016-04 Issue:4 Volume:36 Page:770-777
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

Sarao Valentina,Parravano Mariacristina,Veritti Daniele,Arias Luis,Varano Monica,Lanzetta Paolo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference41 articles.

1. Age-related macular degeneration and blindness due to neovascular maculopathy.;Ferris;Arch Ophthalmol,1984

2. Neovascular age-related macular degeneration.;Veritti;Ophthalmologica,2012

3. . Ranibizumab for neovascular age-related macular degeneration.;Rosenfeld;N Engl J Med,2006

4. . Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study.;Brown;Ophthalmology,2009

5. Group, Martin DF, Maguire MG, et al.. Ranibizumab and bevacizumab for neovascular age-related macular degeneration.;N Engl J Med,2011

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phage Display Technology in Biomarker Identification with Emphasis on Non-Cancerous Diseases;Molecules;2024-06-25

2. Patient adherence to therapy after switch to aflibercept from bevacizumab or ranibizumab for treatment-refractory neovascular age-related macular degeneration;Indian Journal of Ophthalmology;2023-12-22

3. Analysis of ocular fluid in patients with ranibizumab-recalcitrant neovascular age-related macular degeneration who have serum anti-ranibizumab antibodies;Graefe's Archive for Clinical and Experimental Ophthalmology;2023-06-15

4. Baseline characteristics and treatment response predictive of nAMD outcomes with ranibizumab therapy in treatment-naive patients: the RACER subgroup analysis;BMC Ophthalmology;2023-01-27

5. Treatment of neovascular age-related macular degeneration: insights into drug-switch real-world from the Berlin Macular Registry;Graefe's Archive for Clinical and Experimental Ophthalmology;2023-01-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3